Price action seems to suggest it.

Take a look at the daily chart below:

Today price has finally broken up to the upside.

However, take a look at the weekly chart below:

There is still another hurdle for price action to take out and that is the resistance established back in June and July of last year.  And if today momentum continues on this week, it will be like cutting butter with a hot knife.

Fundamentally speaking, I’ll let you read this article and ponder.

Yes, I’ve already placed my bet on this one.

My 2 cents.

Comments »

The charts below convince me to buy back:

 

For $DCTH above, do you see how the price action is now staying above both two support lines.  There is still the catalyst of May FDA respond; so a possible rally still exists.

 

I like the fact that price action is getting back on top of the down trendline.  Look like it is forming the 3rd wave up.  Remember, the 3rd wave of the Elliott Wave Theory is usually the longest wave of the five waves…

My 2 cents.

Comments »

I love this stock simply because it offers hope to patients suffering from ALS.  Phase I trial has been successful and it looks like FDA is now offering some flexibility by allowing a public forum to air its concern about the issue involving the Phase II trial.

However, to me, the most important part is the break-out chart:

As you can see, while I have bought $CUR before the breakout happens, I’ve been waiting for it to happen.  And today, price action finally break-out of the downtrend line in a BIG way.

I’m a fortunate man this week, most of my biotech stocks I have bought are in green.

Go Biotech!

My 2 cents.

Comments »

I’m thinking it is.

Just look at the headlines:

After Successful ALS Phase I, Neuralstem Branches Out  ($CUR)

Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center ($CUR)

Rejuvenated Regenerative Medicine: Stem Cells and Athersys on the Rise ($ATHX)

Athersys’ MultiStem Platform Tempts Big Pharma And Investors ($ATHX)

Meanwhile, $ATHX daily chart shows a cup & handle pattern with one giant handle:

Is this a good sign with a big handle?  Beat me!  Nevertheless, the chart does look like it has a lot of support in the $1.50 area going back to last year.

$CUR daily chart, on the other hand, is showing a come-back V shape pattern:

I like to see price action breakout of the downtrend line at the $1.20 area to show that it means business.

Either way, I’m betting my 2 cents that 2013 may be a good year for Stem Cells.  And I’m rooting for $CUR to have a successful ALS phase II trial.  It will be a milestone for those who suffers from the disease.

I currently own both $CUR and $ATHX.

My 2 cents.

Comments »